A systematic review of the literature on mechanisms of 5-nitroimidazole resistance inTrichomonas vaginalis

Author:

Graves Keonte J.ORCID,Novak Jan,Secor W. Evan,Kissinger Patricia J.,Schwebke Jane R.,Muzny Christina A.

Abstract

AbstractBackgroundTrichomonas vaginalisis the most common non-viral sexually transmitted infection. 5-Nitroimidazoles [metronidazole (MTZ) and tinidazole (TDZ)] are FDA-approved treatments. To better understand treatment failure, we conducted a systematic review on mechanisms of 5-nitroimidazole resistance.MethodsPubMed, ScienceDirect and EMBASE databases were searched using keywordsTrichomonas vaginalis, trichomoniasis, 5-nitroimidazole, metronidazole, tinidazole and drug resistance. Non-English language articles and articles on other treatments were excluded.ResultsThe search yielded 606 articles, of which 550 were excluded, leaving 58 articles.Trichomonas vaginalisresistance varies and is higher with MTZ (2.2–9.6%) than TDZ (0–2%). Resistance can be aerobic or anaerobic and is relative rather than absolute. Differential expression of enzymes involved in trichomonad energy production and antioxidant defenses affects 5-nitroimidazole drug activation; reduced expression of pyruvate:ferredoxin oxidoreductase, ferredoxin, nitroreductase, hydrogenase, thioredoxin reductase and flavin reductase are implicated in drug resistance.Trichomonas vaginalisinfection withMycoplasma hominisorT. vaginalisvirus has also been associated with resistance.Trichomonas vaginalishas two genotypes, with greater resistance seen in type 2 (vstype 1) populations.Discussion5-Nitroimidazole resistance results from differential expression of enzymes involved in energy production or antioxidant defenses, along with genetic mutations in theT. vaginalisgenome. Alternative treatments outside of the 5-nitroimidazole class are needed.

Publisher

Cambridge University Press (CUP)

Subject

Infectious Diseases,Animal Science and Zoology,Parasitology

Reference97 articles.

1. The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections;Cosar;Annales de l'Institut Pasteur,1959

2. Flagyl (metronidazole);Durel;British Journal of Venereal Diseases,1960

3. A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis

4. Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis;Rossignol;International Journal of Clinical Pharmacology, Therapy, and Toxicology,1984

5. Trichomoniasis: clinical manifestations, diagnosis and management

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3